blinatumomab
amgen,astellas
['leukemia', 'blina ', 'blinatumomab']
game changing study. e1910. rct in frontline ph neg b-all addition of blinatumomab consolidation improves significantly os and efs in mrd2 neg and positive setting #ash2022 blina consolidation should be new soc 
Haematologist- Clinical Director for Research; Honorary Senior Lecturer Newcastle University; Member: national adult ALL, low and high grade lymphoma subgroups